Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabienne Grieu

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Pathology|October 7, 2023
Adequacy of cytology and small biopsy samples obtained with rapid onsite evaluation (ROSE) for predictive biomarker testing in non-small cell lung cancerShona Hendry, Louis Mamotte, Nima Mesbah Ardakani, et al.
Asia-Pacific Journal of Clinical Oncology|May 10, 2014
KRAS mutation testing of metastatic colorectal cancer in Australia: where are we at?Rodney J Scott, Stephen B Fox, Jayesh Desai, et al.
The Journal of Molecular Diagnostics : JMD|January 7, 2018
Droplet Digital PCR for Mutation Detection in Formalin-Fixed, Paraffin-Embedded Melanoma Tissues: A Comparison with Sanger Sequencing and PyrosequencingAshleigh C McEvoy, Benjamin A Wood, Nima M Ardakani, et al.
Scientific Reports|April 16, 2013
A multisite blinded study for the detection of BRAF mutations in formalin-fixed, paraffin-embedded malignant melanomaAnna Richter, Fabienne Grieu, Amerigo Carrello, et al.
The Journal of Molecular Diagnostics : JMD|October 10, 2009
A multicenter blinded study to evaluate KRAS mutation testing methodologies in the clinical settingVicki Whitehall, Kayla Tran, Aarti Umapathy, et al.
International Journal of Cancer|January 30, 2014
Population-based screening for Lynch syndrome in Western AustraliaLyn Schofield, Fabienne Grieu, Benhur Amanuel, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Pathology|October 7, 2023
Adequacy of cytology and small biopsy samples obtained with rapid onsite evaluation (ROSE) for predictive biomarker testing in non-small cell lung cancerShona Hendry, Louis Mamotte, Nima Mesbah Ardakani, et al.
Asia-Pacific Journal of Clinical Oncology|May 10, 2014
KRAS mutation testing of metastatic colorectal cancer in Australia: where are we at?Rodney J Scott, Stephen B Fox, Jayesh Desai, et al.
The Journal of Molecular Diagnostics : JMD|January 7, 2018
Droplet Digital PCR for Mutation Detection in Formalin-Fixed, Paraffin-Embedded Melanoma Tissues: A Comparison with Sanger Sequencing and PyrosequencingAshleigh C McEvoy, Benjamin A Wood, Nima M Ardakani, et al.
Scientific Reports|April 16, 2013
A multisite blinded study for the detection of BRAF mutations in formalin-fixed, paraffin-embedded malignant melanomaAnna Richter, Fabienne Grieu, Amerigo Carrello, et al.
The Journal of Molecular Diagnostics : JMD|October 10, 2009
A multicenter blinded study to evaluate KRAS mutation testing methodologies in the clinical settingVicki Whitehall, Kayla Tran, Aarti Umapathy, et al.
International Journal of Cancer|January 30, 2014
Population-based screening for Lynch syndrome in Western AustraliaLyn Schofield, Fabienne Grieu, Benhur Amanuel, et al.
Pageof 4